Maryland Governor Hogan Announces Maryland’s COVID-19 Vaccination Plan

Governor Hogan Announces Maryland’s COVID-19 Vaccination Plan

Draft Plan Submitted to CDC Emphasizes Safety, Prioritizes Frontline First Responders, Healthcare Workers, and Nursing Homes

ANNAPOLIS, MD (STL.News) Governor Larry Hogan today announced the release of the State of Maryland’s initial draft COVID-19 mass vaccination plan, which was submitted to the Centers for Disease Control and Prevention (CDC) last week. Read the draft plan.

“In anticipation of a COVID-19 vaccine, Maryland stands ready to order, distribute, and administer it effectively and rapidly as soon as a vaccine becomes available,” said Governor Hogan.  “The State of Maryland’s plan for this historic undertaking will immediately make the vaccine available to Marylanders at highest risk of developing complications from COVID-19 as well as our critical frontline health care workers and essential workers in public safety and education.”

“The Maryland Department of Health has worked collaboratively with our many partners in both the public and private sectors to develop a draft plan that will ensure the swift, safe, and equitable administration of a life-saving COVID-19 vaccine,” said Maryland Department of Health (MDH) Secretary Robert R. Neall.  “We stand ready to take additional action and operationalize this effort as soon as a vaccine becomes available.”

“As we learn more, our plan will continue to evolve—but our focus will always be on the safety and efficacy of the COVID-19 vaccine to prevent the spread of the disease among Marylanders,” said MDH Acting Deputy Secretary of Public Health Dr. Jinlene Chan.  “From provider recruitment and enrollment to vaccine storage and reminders about second doses, MDH has taken a very calculated approach to ensure the logistics, operations, and execution of this plan are thorough and efficient.”

Governor Hogan recently toured the headquarters of Novavax, Inc. in Gaithersburg—one of nearly 40 Maryland companies that are working on developing and manufacturing COVID-19 vaccines and therapeutics, improving diagnostic tests, and providing clinical research and technological support to ensure safe and effective health care delivery.

In April, state health officials began multi-agency operational discussions in preparation for a COVID-19 vaccine.  That preparation included reviewing lessons learned from previous pandemics and outbreaks—including the 2009 H1N1 influenza pandemic—as well as previous influenza vaccination campaigns.

NOTE: this is NOT the complete release.

CLICK to VIEW COMPLETE RELEASE

%d bloggers like this: